Corticosteroid addiction and withdrawal in the atopic: The red burning skin syndrome

Clinics in Dermatology

Volumn 21, Issue 3, 2003, Pages 201-214

  Rapaport, Marvin J ^a   Lebwohl, Mark ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; AMOXICILLIN; ANALGESIC AGENT; ANTIFUNGAL AGENT; ANTIGEN; BUDESONIDE; BUTYRIC ACID DERIVATIVE; CEFALEXIN; CIPROFLOXACIN; CLARITHROMYCIN; CLOBETASOL PROPIONATE; COCAMIDOPROPYL BETAINE; CORTICOSTEROID; DICHROMATE POTASSIUM; ESTRADIOL; ESTROGEN; HYDROCORTISONE; HYDROXY 17 BUTYRATE; ITRACONAZOLE; KETOCONAZOLE; LIDOCAINE; NARCOTIC AGENT; NYSTATIN; PREDNISONE; PROGESTERONE; PSEUDOMONIC ACID; SUNSCREEN; TIXOCORTOL; TRIAMCINOLONE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ADRENAL INSUFFICIENCY; ANAL ATROPHODERMA; ANUS DISEASE; ARTICLE; ATOPIC DERMATITIS; BATH; BURNING SENSATION; CARBON DIOXIDE LASER; CAUCASIAN; CHRONIC ACTINIC DERMATITIS LIKE ERUPTION; CHRONIC DISEASE; CLINICAL TRIAL; CONTACT DERMATITIS; CREAM; CUSHING SYNDROME; DERMATITIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DEPENDENCE; DRUG POTENCY; DRUG WITHDRAWAL; DRY SKIN; ECZEMA; ERYTHEMA; EYELID DISEASE; FACE DISORDER; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; LOTION; MEDICAL PROFESSION; OAT; PAIN; PAPULAR SKIN DISEASE; PATCH TEST; PERIANAL ATROPHODERMA; PHYSICAL EXAMINATION; POST LASER PEEL SYNDROME; PRIORITY JOURNAL; PRURITUS; RASH; RED BURNING SKIN SYNDROME; RED FACE SYNDROME; RED SCROTUM SYNDROME; SCROTUM DISORDER; SEBORRHEA; SKIN ATROPHY; SKIN BURNING SENSATION; SKIN DISEASE; SKIN EDEMA; STATUS COSMETICUS; TELANGIECTASIA; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; VASODILATATION; VULVODYNIA; WITHDRAWAL SYNDROME;

EID: 0038054315     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-081X(02)00365-6     Document Type: Article

References (87)

1. Rapaport M.J., Rapaport V. Eyelid dermatitis to red face syndrome to cure clinical experience in 100 cases . J Am Acad Dermatol. 41:1999;435-442.
2. Engasser P.G., Hogan D.J., Stewart L.A., Zug K.A. Evaluation and management of the "red face" Am J Contact Dermatitis. 10:1999;236-239.
3. Garner L.A., Cruz P.D. Jr. Worsening of a recurrent facial eruption despite treatment. Am J Contact Dermatitis. 10:1999;81-82.
4. Katz A.S., Sherertz E.F. Facial dermatitis patch test results and final diagnosis . Am J Contact Dermatitis. 10:1999;153-156.
5. Bender B., Prestia A.E., Lynfield Y.L. The headlight sign in neurodermatitis. Cutis. 5:1969;1406-1408.
6. Rapaport M.J., Rapaport V. Prolonged erythema after facial laser resurfacing or phenol peel secondary to corticosteroid addiction. Dermatol Surg. 25:1999;781-785.
7. Fisher A.A. Part I. "Status cosmeticus:" a cosmetic intolerance syndrome . Cutis. 46:1990;109-110.
8. Fisher A.A. Part II. The management of eyelid dermatitis in patients with "status cosmeticus:" the cosmetic intolerance syndrome . Cutis. 46:1990;199-201.
9. Fisher AA. Cosmetic intolerance syndrome. In: Contact Dermatitis, 4th edition, Rietschel R, Fowler J (Eds.). Philadelphia: Williams & Wilkins 1995:316-8.
10. Fisher B.K. The red scrotum syndrome. Cutis. 60:1997;139-141.
11. Rapaport M. Letters to the editor. Cutis. 61:1998;128B.
12. Fisher B.K. Letters to the Editor. Cutis. 61:1998;128B.
13. Lynch PJ, Edwards L (Eds.). Penile and scrotal pain. In: Genital Dermatology. New York: Churchill Livingstone, 1994: 247-8.
14. English J.C., Laws R.A., Keough G.C., et al. Dermatoses of the glans penis and prepuce. J Am Acad Dermatol. 37:1997;1-24.
15. Mroczkowski T.F. Vulvodynia - a dermatovenereologist's perspective. Int J Dermatol. 37:1998;567-569.
16. Goetsch M.F. Vulvar vestibulitis prevalence and history features in a general gynecological practice population . Am J Obstet Gynecol. 164:1991;1609-1616.
17. Baggish M.S., Miklos J.R. Vulvar pain syndrome a review . Obstet Gynecol Surg. 50:1995;618-627.
18. Lynch P.J. Vulvodynia a syndrome of unexplained vulvar pain, psychologic disability and sexual dysfunction. The 1985 ISSVD Presidential Address . J Reprod Med. 31:1986;773.
19. Goldman L., Kitzmiller K.W. Perianal atrophoderma from topical corticosteroids. Arch Dermatol. 107:1973;611-612.
20. Lim H.W., Buchness M.R., Ashinoff R., Soter N.A. Chronic actinic dermatitis. Arch Dermatol. 126:1990;317-323.
21. Roelandts R. Chronic actinic dermatitis. J Am Acad Dermatol. 28:1993;240-249.
22. Norris P., Hawk J. Chronic actinic dermatitis. A unifying concept. Editorials. Arch Dermatol. 126:1990;376-378.
23. Lim H.W., Morison W.L., Kamide R., et al. Chronic actinic dermatitis. Arch Dermatol. 130:1994;1284-1289.
24. Lim H.W., Cohen D., Soter N.A. Chronic actinic dermatitis results of patch and photopatch tests with compositae, fragrances, and pesticides . J Am Acad Dermatol. 38:1998;108-111.
25. du P. Menage H., Ross J.S., Norris P.G., et al. Contact and photocontact sensitization in chronic actinic dermatitis sesquiterpene lactone mix is an important allergen . Br J Dermatol. 132:1995;543-547.
26. Frain-Bell W., Johnson B.E. Contact allergic sensitivity to plants and the photosensitivity dermatitis and actinic reticuloid syndrome. Br J Dermatol. 101:1979;503-512.
27. Frain-Bell W., Scatchard M. The association of photosensitivity and atopy in the child. Br J Dermatol. 85:1971;105-110.
28. Addo H.A., Ferguson J., Johnson B.E., Frain-Bell W. The relationship between exposure to fragrance materials and persistent light reaction in the photosensitivity dermatitis with actinic reticuloid syndrome. Br J Dermatol. 107:1982;261-274.
29. Deffer T.A., Goette D.K. Distal phalangeal atrophy secondary to topical steroid therapy. Arch Dermatol. 123:1987;571-572.
30. Wolf R., Tur E., Brenner S. Corticosteroid-induced disappearing digit. J Am Acad Dermatol. 23:1990;755-756.
31. Kligman A., Leyden J.J. Adverse effects of fluorinated steroids applied to the face. JAMA. 229:1974;60-62.
32. Leyden J.J., Thew M., Kligman A.M. Steroid rosacea. Arch Dermatol. 110:1974;619-662.
33. Kligman A.M., Frosch P.J. Steroid addiction. Int J Dermatol. 18:1979;23-31.
34. Uehara M., Mitsuyoshi O., Sugiura H. Diagnosis and management of the red face syndrome. Dermatol Ther. 1:1996;19-23.
35. Tada J., Yamasaki H., Toi Y., et al. Is the face and neck pattern of atopic dermatitis in Japan a special variant? Am J Contact Dermatitis. 10:1999;7-11.
36. Maloney B.P., Millman B., Monheit G., McCullough E.G. The etiology of prolonged erythema after chemical peel. Dermatol Surg. 24:1998;337-341.
37. Rendon-Pellerano M.I., Lentini J., Eaglstein W.E., Kirsner R.S., Hanft K., Pardo R.J. Laser resurfacing usual and unusual complications . Dermatol Surg. 25:1999;360-367.
38. Ratner D., Tse Y., Marchell N., et al. Cutaneous laser resurfacing. J Am Acad Dermatol. 41:1999;365-389.
39. Ruiz-Esparza J., Barba-Gomez J.M., Gomez-De La Torre O.L., David L. Erythema after laser skin resurfacing. Dermatol Surg. 24:1998;31-34.
40. Nanni C.A., Alster T.S. Complications of cutaneous laser surgery. Dermatol Surg. 24:1998;209-219.
41. McKay M. Vulvodynia. Arch Dermatol. 125:1989;256-262.
42. Lewis FM, Shah M, Gawkrodger DJ. Contact sensitivity in pruritus vulvae: patch test results and clinical outcome. Am J Contact Dermatitis 1997:137-40.
43. Gilbertson E.O., Spellman M.C., Piacquadio D.J., Mulford M.I. Super potent topical corticosteroids use associated with adrenal suppression clinical considerations . J Am Acad Dermatol. 38:1998;318-321.
44. Yawalkar N., Hari Y., Helbling A., et al. Elevated serum levels of interleukins 5, 6 and 10 in a patient with drug-induced exanthem caused by systemic corticosteroids. J Am Acad Dermatol. 39:1998;790-793.
45. Sorenson G.W., Odom R.B. Axillary and inguinal striae induced by systemic absorption of a topical corticosteroid. Cutis. 17:1976;355-356.
46. Ruzicka T., Assmann T., Homey B. Tacrolimus. The Drug for the Turn of the Millennium? Arch Dermatol. 135:1999;574-580.
47. Jolles S., Hughes J., Rustin M. Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis. J Am Acad Dermatol. 40:1999;121-123.
48. Noosari H., Anhalt G., Morrison W. Mycophenolate in Psoralen-UV-A desensitization therapy for chronic actinic dermatitis. Arch Dermatol. 135:1999;1128-1129.
49. Albert M.R., Chang Y.C., Gonzalez E. Concomitant positive reactions to allergens in a patch testing standard series from 1988-1997. Am J Contact Dermatitis. 10:1999;219-223.
50. Williams H. Diagnostic criteria for atopic dermatitis. Where do we go from here? Arch Dermatol. 135:1999;583-586.
51. Dooms-Goossens A. Corticosteroid contact allergy a challenge to patch testing . Am J Contact Dermatitis. 4:1993;120-122.
52. Jagodzinski L.J., Taylor J.S., Oriba H. Allergic contact dermatitis from topical corticosteroid preparations. Am J Contact Dermatitis. 6:1995;67-74.
53. Schoenmakers A., Vermorken A., Degreef H., Dooms-Goossens A. Corticosteroid or steroid allergy? Contact Dermatitis. 26:1992;159-162.
54. Thomson K.F., Wilkinson S.M., Powell S., Beck M.H. The prevalence of corticosteroid allergy in two U. K. centres prescribing implications . Br J Dermatol. 141:1999;863-866.
55. Wilkinson S.M., English J.S.C. Hydrocortisone sensitivity clinical features of fifty-nine cases . J Am Acad Dermatol. 27:1992;683-687.
56. Atkinson S.M., Beck M.H. Is tixocortol pivalate a photoallergen? Contact Dermatitis. 33:1995;55-56.
57. Dooms-Goossens A. What's new in contact dermatitis. Am J Contact Dermatitis. 4:1993;120-122.
58. Reitamo S., Lauerma S., Stubb S., et al. Delayed hypersensitivity to topical corticosteroids. J Am Acad Dermatol. 14:1986;582-598.
59. Guin J.D. Contact sensitivity to topical corticosteroids. J Am Acad Dermatol. 10:1884;773-782.
60. Wilkinson S.M., English J.S.C. Patch tests are poor detectors of corticosteroid allergy. Contact Dermatitis. 26:1992;67-68.
61. Lauerma A.I., Kanerva L. Contact allergy to corticosteroids. Int J Dermatol. 35:1996;92-94.
62. Murata Y., Kumano K., Ueda T., et al. Systemic contact dermatitis caused by systemic corticosteroid use. Arch Dermatol. 133:1997;1053-1054.
63. English J.S.C., Ford G., Beck M.H., et al. Allergic contact dermatitis from topical and systemic steroids. Contact Dermatitis. 23:1990;196-198.
64. Lauerma A.I., Reitamo S. Contact allergy to corticosteroids. J Am Acad Dermatol. 28:1993;618-622.
65. Whitmore E. Delayed systemic allergic reactions to corticosteroids. Contact Dermatitis. 32:1995;193-198.
66. Sholz J.R. Corticosteroid contact allergic dermatitis - some questions. Am J Contact Dermatitis. 1:1990;14-142.
67. Dooms-Goossens A. Allergy to inhaled corticosteroids a review . Am J Contact Dermatitis. 6:1995;1-3.
68. Bircher A.J. Short induction phase of contact allergy to tixocortol pivalate in a nasal spray. Contact Dermatitis. 227:1990;237-238.
69. Clark RJ. Exacerbation of asthma after nebulised beclomethasone dipropionate. Lancet 1986:574-5.
70. McGivern D.V., MacFarlane J.T. Severe bronchoconstriction after inhalation of budesonide. Br Med J. 288:1984;447-449.
71. Pierard G.E., Pierard-Franchimont C., Mosbah T., et al. Adverse effects of topical corticosteroids. Acta Derm Venereol (Stockh). 69:1989;26-30.
72. Callens A., Vaillant L., Machet C., et al. Contact stomatitis from tixocortol pivalate. Contact Dermatitis. 29:1993;161.
73. Meding B., Dahlberg E. Contact allergy to budesonide in a nasal spray. Contact Dermatitis. 14:1986;253-254.
74. Willan, C. Steroid creams sell briskly (and illicitly) as cosmetics. Wall Street J, August 1999; Health: B1.
75. Keane F.M. Analysis of Chinese herbal creams prescribed for dermatologic conditions. Br J Med. 318:1999;563-564.
76. Katz I.H., Prawer S.E., Mooney J.J., et al. Preatrophy covert sign of thinned skin . J Am Acad Dermatol. 20:1989;731-735.
77. du Vivier A. Tachyphylaxis to topically applied steroids. Arch Dermatol. 76:(112):1976;1245-1248.
78. Dykes P.J., Marks R. An appraisal of the methods used in the assessment of atrophy from topical steroids. Br J Dermatol. 101:1979;599-606.
79. Lavker R.M., Schechter N.M., Lazarus G.S. Effects of topical corticosteroids on human dermis. Br J Dermatol. 115:1986;101-107.
80. Shah V.P., Peck C.C., Skelly J.P. Vasoconstriction-skin blanching-assay for glucocorticoids - a Critique. Arch Dermatol. 125:1989;1558-1561.
81. Marks R., Sawyer M. Glucocorticoid-induced vasoconstriction in human skin. Arch Dermatol. 122:1986;881-883.
82. Hogan DJ, Rooney ME. Facial telangiectasias associated with long-term application of a topical corticosteroid to the scalp. J Am Acad Dermatol 1089;20:1129-30.
83. Hessel A., Zyniewicz K. Facial blanching caused by superpotent corticosteroids. Cutis. 48:1991;395-396.
84. Lepoittevin J.P., Drieghe J., Dooms-Goossens A. Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. Arch Dermatol. 131:1995;31-37.
85. Kalish R.S. Studies in patients with corticosteroid contact allergy a flawed analysis of structure-function relationships . Arch Dermatol. 131:1995;851-852.
86. Ganong W.F. Cardiovascular regulatory mechanisms. Holmes S.A. Review of medical physiology. 1991;50-51 Appleton & Lange, Norwalk (CT).
87. th ed: 1998;429-432 Mosby, St. Louis.